S'abonner

Meta-Analysis: Relapse Prevention Strategies for Depression and Anxiety in Remitted Adolescents and Young Adults - 24/02/23

Doi : 10.1016/j.jaac.2022.04.014 
Suzanne J. Robberegt, MSc a, c, Marlies E. Brouwer, PhD a, Bas E.A.M. Kooiman, MSc c, e, Yvonne A.J. Stikkelbroek, PhD c, d, Maaike H. Nauta, PhD e, f, Claudi L.H. Bockting, PhD a, b,
a Amsterdam University Medical Centers, University of Amsterdam, the Netherlands 
b Centre for Urban Mental Health, University of Amsterdam, the Netherlands 
c Depression Expertise Centre-Youth, GGZ Oost Brabant, the Netherlands 
d Utrecht University, the Netherlands 
e University of Groningen, the Netherlands 
f Accare Child Study Centre, the Netherlands 

Correspondence to Professor Claudi Bockting, PhD, Department of Psychiatry, Amsterdam University Medical Centers, location AMC, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, the NetherlandsDepartment of PsychiatryAmsterdam University Medical Centerslocation AMCUniversity of AmsterdamMeibergdreef 5Amsterdam1105 AZthe Netherlands

Abstract

Objective

Depression and anxiety cause a high burden of disease and have high relapse rates (39%-72%). This meta-analysis systematically examined effectiveness of relapse prevention strategies on risk of and time to relapse in youth who remitted.

Method

PubMed, PsycInfo, Embase, Cochrane, and ERIC databases were searched up to June 15, 2021. Eligible studies compared relapse prevention strategies to control conditions among youth (mean age 13-25 years) who were previously depressed or anxious or with ≥30% improvement in symptoms. Two reviewers independently assessed titles, abstracts, and full texts; extracted study data; and assessed risk of bias and overall strength of evidence. Random-effects models were used to pool results, and mixed-effects models were used for subgroup analyses. Main outcome was relapse rate at last follow-up (PROSPERO ID: CRD42020149326).

Results

Of 10 randomized controlled trials (RCTs) that examined depression, 9 were eligible for analysis: 4 included psychological interventions (n = 370), 3 included antidepressants (n = 80), and 2 included combinations (n = 132). No RCTs for anxiety were identified. Over 6 to 75 months, relapse was half as likely following psychological treatment compared with care as usual conditions (k = 6; odds ratio 0.56, 95% CI 0.31 to 1.00). Sensitivity analyses including only studies with ≥50 participants (k = 3), showed similar results. Over 6 to 12 months, relapse was less likely in youth receiving antidepressants compared with youth receiving pill placebo (k = 3; OR 0.29, 95% CI 0.10 to 0.82). Quality of studies was suboptimal.

Conclusion

Relapse prevention strategies for youth depression reduce risk of relapse, although adequately powered, high-quality RCTs are needed. This finding, together with the lack of RCTs on anxiety, underscores the need to examine relapse prevention in youth facing these common mental health conditions.

Le texte complet de cet article est disponible en PDF.

Key words : anxiety disorders, depressive disorders, intervention, meta-analysis, relapse prevention


Plan


 This work was supported by a grant from the Netherlands Organization for Health Research and Development (636310007), GGZ Oost Brabant, Accare, RINO Zuid, and the University of Groningen. The Netherlands Organization for Health Research and Development, GGZ Oost Brabant, Accare, RINO Zuid, and the University of Groningen had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
 This work has been prospectively registered: display_record.php?ID=CRD42020149326.
 Author Contributions
 Conceptualization: Robberegt, Brouwer, Kooiman, Stikkelbroek, Nauta, Bockting
 Data curation: Robberegt, Brouwer, Bockting
 Formal analysis: Robberegt, Brouwer
 Funding acquisition: Stikkelbroek, Nauta, Bockting
 Investigation: Robberegt, Brouwer, Kooiman, Nauta
 Methodology: Robberegt, Brouwer, Kooiman, Stikkelbroek, Nauta, Bockting
 Project administration: Robberegt, Brouwer, Bockting
 Resources: Brouwer, Bockting
 Software: Robberegt, Brouwer
 Supervision: Brouwer, Stikkelbroek, Nauta, Bockting
 Validation: Robberegt, Brouwer, Kooiman
 Visualization: Robberegt, Brouwer
 Writing – original draft: Robberegt, Brouwer, Bockting
 Writing – review and editing: Robberegt, Brouwer, Kooiman, Stikkelbroek, Nauta, Bockting
 The authors wish to thank Celine Breurken, MSc, and Rosa Joosten, MSc, of GGZ Oost Brabant, Tritia van der Velde, BSc, and Hedwich Boelens, BSc, of the University of Groningen, and Romy Stuik, BSc, of the University of Amsterdam, for assistance in screening and selecting articles, data extraction, and risk of bias assessments.
 Disclosure: Dr. Stikkelbroek, Profs. Nauta and Bockting, Ms. Robberegt, and Mr. Kooiman have reported they are co-developers of the StayFine app, a personalized guided app-based relapse prevention intervention for remitted youth with a history of depressive or anxiety disorders. The StayFine app is based on preventive cognitive therapy of Prof. Bockting. Dr. Brouwer has reported no biomedical financial interests or potential conflicts of interest.


© 2022  American Academy of Child and Adolescent Psychiatry. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 62 - N° 3

P. 306-317 - mars 2023 Retour au numéro
Article précédent Article précédent
  • Review: Defining Positive Emotion Dysregulation: Integrating Temperamental and Clinical Perspectives
  • Alecia C. Vogel, Melissa A. Brotman, Amy Krain Roy, Susan B. Perlman
| Article suivant Article suivant
  • Systematic Review and Meta-analysis: Pharmacological and Nonpharmacological Interventions for Persistent Nonepisodic Irritability
  • Rosanna Breaux, Raman Baweja, Hana-May Eadeh, Delshad M. Shroff, Annah R. Cash, Courtney S. Swanson, Amy Knehans, James G. Waxmonsky

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.